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LETTERS TO THE EDITOR
DNA Photodamage Induced by UV Phototherapy Lamps and
Sunlamps in Human Skin In Situ and its Potential Importance
for Skin Cancer
To the Editor:
Ultraviolet radiation (UVR) from arti®cial sunlamps has been used
for many years to treat skin diseases and to obtain a cosmetic tan at
home or in a commercial salon. More than 40 kinds of skin diseases
can be treated with arti®cial UVR by three types of phototherapy,
i.e., broadband UVB phototherapy, narrowband UVB photo-
therapy, and UVA phototherapy (Morison, 1999). Phototherapy
combined with some chemicals (e.g., psoralen) (photochemo-
therapy) is also used to treat certain skin diseases, mainly psoriasis
(Lauharanta, 1997; Lowe et al, 1997; Morison, 1999). In addition to
the phototherapeutic applications, arti®cial sunlamp use for
recreational and cosmetic purposes has become popular in recent
years (Oliphant et al, 1994; Bulman, 1995; Boldeman et al, 1996).
No matter which purpose is pursued with arti®cial UVR, long-
term and high dose of exposure is quite common (Diffey, 1990;
Miller et al, 1998).
UVR is like a double-edged sword with advantages and
disadvantages for humans. In addition to the short-term adverse
effects after exposure to UVR from sunlamps (e.g., erythema),
long-term adverse effects (e.g., photoageing and skin cancer) may
also result (Swerdlow and Weinstock, 1998; Morison, 1999).
Epidemiologic studies have shown an increased risk for melanoma
in sunlamp users (Chen et al, 1998; Walter et al, 1999; Westerdahl
et al 2000). These recent studies add to the previous limited
evidence on sunlamp use and melanoma (Swerdlow and
Weinstock, 1998). It is well known that UVR can induce
mutagenic and carcinogenic DNA lesions, mainly cyclobutane
pyrimidine dimers (CPD) and 6±4 photoproducts. In vitro studies
have shown DNA damage in human ®broblasts and keratinocytes
after exposure to arti®cial UVA lamps (Woollons et al, 1997, 1999).
Yet, direct evidence on DNA damage in human skin after sunlamp
applications, which can provide molecular evidence for sunlamp
use and skin cancer, is lacking. For this study, we selected two kinds
of sunlamps (UVA lamp, Waldmann 85/100w-PUVA, Sylvania,
~1.5% of output at < 315 nm, with maximum peak at 355 nm;
UVB lamp, Waldmann 85/100w-UV21, Philips, 0.5% of output
< 280 nm, with maximum peak at 315 nm), which are commonly
used for the treatment of skin diseases and for tanning purposes, to
explore sunlamp-induced DNA damages in human skin in situ and
its potential importance for skin cancer. The selected doses were
automatically administered with a Waldman UV 3003 K sensor
calibrated to a distance of 30 cm.
In study I, seven healthy female hospital staff (mean age 43 y)
were exposed to clinically frequently used UVR devices (10 J per
cm2 of UVA and 0.2 J per cm2 of UVB) on the buttock skins. In
study II, seven new volunteers (three males and four females, mean
age 47 y) were whole body exposed (including the buttock area) to
UVA 20 J per cm2 for 5 d (Monday through Friday). On the
following Monday, the treatment was resumed as described. Thus
10 exposures were given. For the skin biopsies a 4 mm diameter
punch was used after anesthesization with Xylocain-epinephrine
(Astrazeneca, SoÈdertaÈlje, Sweden). All the biopsies were taken
within 10 min after irradiation and were immediately put on dry
ice, frozen, and stored at ±20°C until DNA isolation. In study II,
the biopsies were taken on Fridays after the ®fth and tenth
irradiation, respectively. Preirradiation biopsies were taken as
controls.
The 32P-postlabeling method was used to quantify the photo-
product levels in epidermal DNA as described (Bykov and
Hemminki, 1995; Xu et al 2000). The photoproducts were assayed
as a trinucleotide with an unmodi®ed nucleotide at the 5¢-side. In
this study, four kinds of photoproducts were determined, TT=C,
TT=T as CPDs and TT-C, TT-T as 6±4 photoproducts. Each
sample was analyzed twice.
There were no detectable photoproducts in any of the
preirradiation skin biopsies, so only data on UVR-exposed samples
were presented. We de®ned the level as undetectable when the
signal of the relevant fraction did not reach two times that of the
background noise levels in HPLC chromatography.
Irradiation with 10 J per cm2 UVA or 0.2 J per cm2 UVB
induced photoproducts in human skin in situ (Table I). The UVB
lamp was much more ef®cient than the UVA lamp at the doses
used. TT=T was more abundant than TT=C but the relative
proportion of these were different after UVA and UVB, 3.4 after
UVA and 2.1 after UVB (Table I). The relative proportion of
TT=T to TT-T changed even more depending on the UV source
(Table I).
Irradiation with 20 J per cm2 of UVA per day for 5 or 10 d
induced photoproducts at levels higher than those observed after a
single exposure on different subjects (Table II); however, compar-
ison of photoproduct levels produced after the ®fth and the tenth
UVA exposure showed no large difference (p > 0.05) (Table II).
In this study, two UV lamps commonly used for dermatologic
treatment and tanning purposes were selected to assess DNA
damage in human skin in situ. It was clearly shown that UV lamps
could induce detectable DNA damage in the sunlamp user's skin
in situ for both phototherapeutic and cosmetic applications
(Tables I and II). Irradiation with the UVB lamp induced more
DNA damage than with the UVA lamp. This is not surprising
because DNA absorbs more UV radiation in the UVB range than
in the UVA range (IARC, 1992). In phototherapy, both UVB and
UVA are used (Jekler and Larko, 1990, 1991a, ,b). For those whose
disease is suitable for UVB treatment, both the UVB dose and the
number of treatments should be taken into account due to much
more DNA damage induced by UVB lamp.
It is known that photoproducts are mutagenic and probably
carcinogenic and that they are slowly repaired in the p53 mutation
hotspots for skin cancer (Tornaletti and Pfeifer, 1994). Assuming
that these UV lamps are used in sun parlors, enormous DNA
damage would be expected in users' skin. A frequent sunlamp
tanner (100 sessions per year, Miller et al, 1998) will produce 100
times higher cumulative amounts of CPD in skin than a single
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UVA lamp exposure (10 J per cm2) and ®ve times more than a
typical sunlamp tanner (20 sessions per year, Miller et al, 1998).
During the treatment for psoriasis with a UVB lamp (20 exposures,
IARC, 1992), the patient will receive 20 times higher cumulative
amounts of CPD than in a single UVB lamp exposure (0.2 J per
cm2). Epidemiologic studies have shown that the increased risk in
skin cancer (both melanoma and nonmelanoma) is related to UVR
exposure during tanning and psoriasis treatment (Chen et al, 1998;
Frentz et al, 1999; Walter et al, 1999; Hannuksela-Svahn et al 2000;
Westerdahl et al 2000). The vast amounts of DNA damage induced
during chronic sunlamp use, if unrepaired, will increase the
possibility of tumorigenesis in skin. Our results showed biologic
plausibility at the molecular level for possible carcinogenic effects of
sunlamp applications.
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Table I. UVB lamp was more ef®cient to induce DNA photodamage than UVA lamp in human skin in situ
TT=C TT=T TT-C TT±T TT=T/TT=C TT=T/TT±T TT=C/TT±C
(n=7) (n=7) (n=7) (n=7)
10 J per cm2 UVA 1.1560.25 3.9260.72 0.3460.11 0.1760.08 3.41 23.06 3.38
0.2 J per cm2 UVB 17.8262.02* 37.5265.03* 4.3160.53* 4.2560.44* 2.10 8.83 4.13
aMean6SD, per 106 Nt; study I.
Nt, nucleotide. *Differences in photoproduct levels after 0.2 J per cm2 UVB and 10 J per cm2 UVA irradiation were analysed by Student's t test, p<0.01.
Table II. Repetitive UVA irradiation induced DNA photodamages in human skin in situ
TT=C TT=T TT-C TT±T TT=T/TT=C
(n=7) (n=7) (n=7) (n=7)
20 J per cm2 UVA (35 d) 2.5860.83 10.2062.76 0.1660.17 0.2160.21 3.95
20 J per cm2 UVA (310 d) 2.1260.59 10.9762.82 0.1760.29 0.5160.38 5.17
aMean6SD, per 106 Nt; study II.
Nt, nucleotide.
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